About: NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Medical Devices
Latest price: $12.88 (-0.92%)
NPCE NASDAQ Neuropace Inc
Neuropace Inc share price
NPCE price activity
Last Price
$12.880
Change (24hr)
-0.12 USD (-0.92%)
Volume
17.80K
Volume (4w avg)
-
Open
$13.23
Day Range
$12.88 - $13.23
Previous Close
$13.00
Last Trade
13 Oct, 4:13 pm GMT+0
Delayed
13 Oct, 4:13 pm GMT+0
NPCE price performance
Delayed
13 Oct, 4:13 pm GMT+0
NPCE Market Signals